Quinolone susceptibility of norA-disrupted Staphylococcus aureus - PubMed (original) (raw)

Quinolone susceptibility of norA-disrupted Staphylococcus aureus

H Yamada et al. Antimicrob Agents Chemother. 1997 Oct.

Abstract

The MIC of norfloxacin for the norA-disrupted mutant termed RDN1, obtained from quinolone-susceptible Staphylococcus aureus RN4220, was eightfold lower than that for RN4220. The increase in susceptibility was related to an increase of drug accumulation by RDN1. These results indicate that NorA plays an important role in the susceptibility of quinolone-susceptible S. aureus to selected quinolones.

PubMed Disclaimer

References

    1. Antimicrob Agents Chemother. 1988 Apr;32(4):438-42 -PubMed
    1. Antimicrob Agents Chemother. 1989 Sep;33(9):1535-9 -PubMed
    1. Antimicrob Agents Chemother. 1996 Aug;40(8):1835-42 -PubMed
    1. J Bacteriol. 1990 Dec;172(12):6942-9 -PubMed
    1. N Engl J Med. 1991 Feb 7;324(6):384-94 -PubMed

MeSH terms

Substances

LinkOut - more resources